We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New World Research Headquarters for Novartis

By Biotechdaily staff writers
Posted on 15 Nov 2002
Following a worldwide search, one of Europe's leading pharmaceutical companies has chosen Cambridge, MA (USA), as the site of its new world research headquarters, to be called Novartis Institute of Biomedical Research. More...


Novartis (Basel, Switzerland) has leased around 764,000 square feet of space in Cambridge, where renovated laboratories will accommodate around 1,000 workers. This new research center will supplant the lead role of the company's research center in Basel (Switzerland). Novartis says it expects to spend about US$750 million on developing, equipping, and staffing the new research center.

The site is close to the Massachusetts Institute of Technology and Harvard University as well as a large number of biopharmaceutical companies. Industry analysts speculate that the location was chosen because it will provide Novartis with access to US talent and consumers while allowing the company to evade the regulatory complexities of the European biopharmaceutical industry. Novartis research centers in other US states and in Japan will continue to operate as before, says the company.




Related Links:
Novartis

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.